A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension
Sponsor study identifier
interventional
106
1 country
1
Study Start
May 17, 2017
Actual (reported)Primary Completion
April 30, 2018
Actual (reported)Study Completion
April 30, 2018
Actual (reported)The purpose of this study is to determine superiority of YHP1701 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 22, 2017
Actual (reported)April 6, 2017
Actual (reported)May 17, 2017
Actual (reported)April 30, 2018
Actual (reported)April 30, 2018
Actual (reported)Percent change of LDL-Cholesterol
LDL-Cholesterol
0, 8 weeks
Change of mean seated Systolic Blood Pressure
Blood Pressure
0, 8 weeks
PO, Once daily (QD), 8 weeks
PO, Once daily (QD), 8 weeks
PO, Once daily (QD), 8 weeks
PO, Once daily (QD), 8 weeks
PO, Once daily (QD), 8 weeks
Seoul Medical Center
Seoul, South Korea
Kim W, Chang K, Cho EJ, Ahn JC, Yu CW, Cho KI, Kim YJ, Kang DH, Kim SY, Lee SH, Kim U, Kim SJ, Ahn YK, Lee CH, Shin JH, Kim M, Park CG. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension. J Clin Hypertens (Greenwich). 2020 Feb;22(2):261-269. doi: 10.1111/jch.13774. Epub 2020 Jan 31.
Andrew Lee
Yuhan Corporation
106 participants (actual enrollment reported by the registry).
First Submitted
March 22, 2017
First Posted
April 6, 2017
Study Start
May 17, 2017
Actual (reported)PO, Once daily (QD), 8 weeks
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 30, 2018
Actual (reported)Study Completion
April 30, 2018
Actual (reported)Last Updated
September 7, 2018
Record last verified: 2018-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: